title: Are guidelines needed for the perioperative discontinuation of phosphodiesterase type 5 inhibitors?
authors.forename: Russell K
authors.initials: RK
authors.lastname: McAllister
authors.forename: Tricia A
authors.initials: TA
authors.lastname: Meyer
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Bittenbinder
mesh_terms: D017408:Guidelines as Topic / Q000592:standards; D006801:Humans; D008297:Male; D018917:Optic Neuropathy, Ischemic / Q000139:chemically induced / Q000517:prevention & control; D019990:Perioperative Care; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects*
chemical_list: D010726:Phosphodiesterase Inhibitors